Seeing Is Believing

Currently out of the existing stock ratings of Tim Anderson, 24 are a BUY (32%), 39 are a HOLD (52%), 12 are a SELL (16%).
Analyst Tim Anderson, currently employed at BAML, carries an average stock price target met ratio of 81.54% that have a potential upside of 26.9% achieved within 380 days. Previously, Tim Anderson worked at WOLFE.
Tim Anderson’s has documented 147 price targets and ratings displayed on 13 stocks. The coverage is on Industrials, Healthcare sectors.
Most recent stock forecast was given on REGN, Regeneron Pharmaceuticals at 07-Jan-2026.
Analyst best performing recommendations are on MRNA (MODERNA).
The best stock recommendation documented was for MRNA (MODERNA) at 2/11/2025. The price target of $34 was fulfilled within 7 days with a profit of $3.07 (9.93%) receiving and performance score of 14.18.
Average potential price target upside
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
Since 03-Jan-2025
$55
$8.53 (18.36%)
$42
8 days ago
(08-Jan-2026)
18/25 (72%)
$9.17 (20.01%)
263
Buy
Since 03-Aug-2021
$48
$1.53 (3.29%)
$41
1 months ago
(16-Dec-2025)
6/8 (75%)
$4.78 (11.06%)
161
Hold
Since 05-Oct-2021
$46
$-0.47 (-1.01%)
$44
1 months 8 days ago
(08-Dec-2025)
19/19 (100%)
$4.82 (11.70%)
115
Hold
Since 01-Oct-2013
$40
$-6.47 (-13.92%)
$38
2 months 13 days ago
(03-Nov-2025)
16/18 (88.89%)
$4.5 (12.68%)
183
Hold
Since 25-Jun-2024
$38
$-8.47 (-18.23%)
$37
2 months 16 days ago
(31-Oct-2025)
11/12 (91.67%)
$1.17 (3.18%)
146
Which stock is Tim Anderson is most bullish on?
Which stock is Tim Anderson is most reserved on?
What Year was the first public recommendation made by Tim Anderson?